Patent · US Active

RNA-guided nucleases and active fragments and variants thereof and methods of use

US12398385B2 · kind B2 · utility

0Cited by
0References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 23, 2024
Grant dateAug 26, 2025
Priority date
Expiry dateJul 23, 2044

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N9/22
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and methods for binding to a target sequence of interest are provided. The compositions find use in cleaving or modifying a target sequence of interest, visualization of a target sequence of interest, and modifying the expression of a sequence of interest. Compositions comprise RNA-guided nuclease (RGN) polypeptides, CRISPR RNAs, trans-activating CRISPR RNAs, guide RNAs, and nucleic acid molecules encoding the same. Vectors and host cells comprising the nucleic acid molecules are also provided. Further provided are RGN systems for binding a target sequence of interest, wherein the RGN system comprises an RNA-guided nuclease polypeptide and one or more guide RNAs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.